Today, the National Growth Fund announced that PharmaNL has met the conditions to convert the conditional allocation of €78.8 million into a definitive grant.
“We at PharmaNL are delighted with this news. Together with stakeholders, we can now begin implementing the ambitions of PharmaNL,” said Brigitte Drees, Director of Pivot Park.
Click here to view the official announcement from the Dutch government.
PharmaNL is a national public-private consortium comprising Leiden University Medical Center, Leiden University, Campus Groningen, and Pivot Park, working closely with FAST - Platform to Future Affordable Sustainable Therapies.
PharmaNL is kicking off with €80 million in funding from the National Growth Fund to invest in research facilities and human capital.
Source: PharmaNL
MimeCure heeft een investering van 3 miljoen euro binnengehaald voor de ontwikkeling van een regeneratief geneesmiddel voor de behandeling van chronische longziekten, zoals longfibrose. Dankzij deze financiering kan MimeCure de afronding van de preklinische fase versnellen en beginnen met de voorbereidingen voor klinische proeven, die volgens planning eind 2027 van start zullen gaan. De investeringsronde wordt geleid door Addington Investment Group en ondersteund door mede-investeerder Apsara Investments.
Turning plans into results: that is the central focus of the fifth LIFE Science Conference, taking place on Tuesday, 22 September 2026 at Forum Groningen. The LIFE Cooperative will bring together professionals, entrepreneurs, researchers and policymakers from the life sciences and health sector around one key question: how do we translate vision into concrete impact? The keynote speaker will be Peter Wennink, former CEO of ASML and one of the most influential leaders in the Dutch technology sector. In 2025, he presented his advisory report ‘The Road to Future Prosperity’, in which he advocates targeted investments in innovation to strengthen the Netherlands’ long-term earning capacity.
In the North, and in Groningen in particular, there are dozens of companies working on innovations in the fields of life sciences and health. There are many hidden gems among them, says Ronald Hesse, director of the LIFE Cooperative partnership. “Millions of patients worldwide have already benefited from innovations developed here in Groningen,” he says.
